,bcr_patient_uuid,patient_ID,bcr_drug_barcode,bcr_drug_uuid,form_completion_date,pharmaceutical_therapy_drug_name,clinical_trial_drug_classification,pharmaceutical_therapy_type,days_to_drug_start,pharmaceutical_tx_ongoing_indicator,days_to_drug_end,treatment_best_response,days_to_stem_cell_transplantation,pharm_regimen,pharm_regimen_other,drug_cycles,pharma_type_other,drug_units,drug_tota_dose_units,drug_dose,regimen_number,drug_route,stem_cell_transplantation,stem_cell_transplantation_type,therapy_regimen,therapy_regimen_other,drug_total_dose,therapy_on_clinical_trial
1,8ee720b5-6f3a-4921-85ab-70e75c0835b0,TCGA.A3.3317,TCGA-A3-3317-D1484,7e3935a4-8f96-406a-a319-7377608652fa,2010-5-13,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,605,FALSE,886,NA,NA,NA,NA,NA,NA,MG,NA,800,NA,ORAL,NA,NA,RECURRENCE,NA,NA,NA
2,8ee720b5-6f3a-4921-85ab-70e75c0835b0,TCGA.A3.3317,TCGA-A3-3317-D1485,e64308cc-327e-4629-94e4-c6c056787f2b,2010-5-13,INTERFERON ALPHA,NA,IMMUNOTHERAPY,605,FALSE,886,NA,NA,NA,NA,NA,NA,M[IU],NA,0.5,NA,SUBCUTANEOUS,NA,NA,RECURRENCE,NA,NA,NA
3,3372a7d2-79cb-4cf0-9a7e-fe1a6b205daa,TCGA.A3.3347,TCGA-A3-3347-D4931,c055dcd8-9968-40c8-9107-059cf2adea95,2010-9-12,PERIFOSINE,NA,TARGETED MOLECULAR THERAPY,1097,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,ORAL,NA,NA,PROGRESSION,NA,NA,NA
4,3372a7d2-79cb-4cf0-9a7e-fe1a6b205daa,TCGA.A3.3347,TCGA-A3-3347-D4930,2610bbd4-b2a1-4e02-bf42-3b575f94f763,2010-9-12,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,NA,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,ORAL,NA,NA,ADJUVANT,NA,NA,NA
5,c5265ca6-2cb5-406d-a635-c4c783561107,TCGA.AK.3426,TCGA-AK-3426-D4313,3ebcad24-5a0f-4565-9401-f3ebf8fefad7,2010-11-10,INTERFERON,NA,IMMUNOTHERAPY,465,FALSE,522,NA,NA,NA,NA,NA,NA,NA,NA,3,1,SUBCUTANEOUS,NA,NA,RECURRENCE,NA,NA,NA
6,b2feca3f-8602-4a30-92bf-958ab2a2bd5d,TCGA.AK.3436,TCGA-AK-3436-D4346,200c01cf-2051-46d4-a755-4b291b488e77,2010-11-12,SUTENT,NA,CHEMOTHERAPY,76,TRUE,NA,NA,NA,NA,NA,NA,NA,MG,NA,37.5,1,ORAL,NA,NA,ADJUVANT,NA,NA,NA
7,b2feca3f-8602-4a30-92bf-958ab2a2bd5d,TCGA.AK.3436,TCGA-AK-3436-D66269,E1720391-E83A-499D-8AA3-FBDFC1EB92D3,2014-10-7,SUTENT,NA,CHEMOTHERAPY,1194,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
8,fd5728e0-e495-45f5-aac8-c0856510c8aa,TCGA.AK.3453,TCGA-AK-3453-D4355,c4d89674-4155-4d65-8c93-6a0a92e587be,2010-11-12,NA,NA,CHEMOTHERAPY,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,ADJUVANT,NA,NA,NA
9,75801b19-6569-4345-8134-82344a412c21,TCGA.B0.4718,TCGA-B0-4718-D71492,CD80DE57-91F5-4915-970A-63855FA51F49,2015-3-26,PAZOPANIB,NA,CHEMOTHERAPY,99,FALSE,1231,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
10,75801b19-6569-4345-8134-82344a412c21,TCGA.B0.4718,TCGA-B0-4718-D71493,2FDAAE91-FC6E-47C8-B600-0C2719CD0119,2015-3-26,BEVACIZUMAB,NA,CHEMOTHERAPY,1363,FALSE,1685,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE
11,31e9d2fc-79fa-49db-adac-7afb9609f915,TCGA.B0.4837,TCGA-B0-4837-D31227,f44ccd53-1fa1-47aa-9344-0a6c8dff1cf2,2012-4-25,TYROSINE KINASE INHIBITOR,NA,IMMUNOTHERAPY,1217,FALSE,NA,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
12,77d8c2cf-6b27-417b-9d43-14c95e6f9b85,TCGA.B0.4841,TCGA-B0-4841-D31237,af206997-7393-4f9e-a9d0-6dee745c7585,2012-4-25,INF,NA,IMMUNOTHERAPY,47,FALSE,108,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
13,4ee14e95-09d8-4512-b358-3e0e7cb74c9a,TCGA.B0.4844,TCGA-B0-4844-D30999,e5d040d0-8f40-42dc-afa0-a5318868d569,2012-4-20,IL-2,NA,CHEMOTHERAPY,60,FALSE,NA,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
14,4ee14e95-09d8-4512-b358-3e0e7cb74c9a,TCGA.B0.4844,TCGA-B0-4844-D31001,c3a07cf7-d164-4b2a-8fdb-c8dde5243f59,2012-4-20,THALIDOMIDE,NA,CHEMOTHERAPY,60,FALSE,NA,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
15,8aaa4e25-5c12-4ace-96dc-91aaa0c4457c,TCGA.B0.5094,TCGA-B0-5094-D31511,e973d23d-8bec-4f9b-99c0-e10fbb0d6468,2012-5-4,TORISEL,NA,CHEMOTHERAPY,124,FALSE,228,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
16,6b1ff32f-75a4-44aa-9da4-b6872e179c9f,TCGA.B0.5107,TCGA-B0-5107-D31607,1e2025bb-698c-4a31-9302-fe90f67db312,2012-5-7,SUTENT,NA,CHEMOTHERAPY,11,FALSE,NA,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
17,46bc69a9-0090-4809-92b8-8cb741d9007d,TCGA.B0.5115,TCGA-B0-5115-D31669,4394ed12-bf7a-429b-99c5-191808378871,2012-5-8,PAZOPANIB,NA,CHEMOTHERAPY,197,FALSE,197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
18,46bc69a9-0090-4809-92b8-8cb741d9007d,TCGA.B0.5115,TCGA-B0-5115-D31670,cbb89ea4-88a3-4965-8468-5462ed62b9fe,2012-5-8,AFINITOR,NA,CHEMOTHERAPY,501,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
19,11111b58-c7df-4291-ad8a-4baec9ff7d1f,TCGA.B0.5694,TCGA-B0-5694-D31875,4ac87a38-e1a6-4778-8a93-48f6dc837641,2012-5-10,PAZOPANIB,NA,CHEMOTHERAPY,441,FALSE,469,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
20,8f8a632d-7fbd-4c86-b909-afb7edb9ad28,TCGA.B0.5701,TCGA-B0-5701-D72539,5ED37448-8F4C-4B40-BA79-879C0E7025EC,2015-7-13,INTERLEUKIN-2,NA,IMMUNOTHERAPY,366,FALSE,727,COMPLETE RESPONSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
21,514af471-31d2-43fa-88dc-8639a5e97181,TCGA.B0.5712,TCGA-B0-5712-D31971,fcf69248-81ae-4ab6-a197-b2b486da9e71,2012-5-14,ZOMETA,NA,NA,177,FALSE,NA,STABLE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
22,73cb1350-7590-4f79-bb86-3f395466652e,TCGA.B2.5639,TCGA-B2-5639-D15087,a9334672-bbcb-4c0e-bc83-8e6e7dfdaedf,2011-8-11,TORISEL,NA,CHEMOTHERAPY,74,FALSE,158,NA,NA,NA,NA,11,NA,MG,MG,25,1,INTRAVENOUS,NA,NA,ADJUVANT,NA,275,NA
23,73cb1350-7590-4f79-bb86-3f395466652e,TCGA.B2.5639,TCGA-B2-5639-D15321,036f3dd6-adad-435e-a474-903e289d323f,2011-8-17,VOTRIENT,NA,CHEMOTHERAPY,177,TRUE,NA,NA,NA,NA,NA,241,NA,MG,NA,200,2,ORAL,NA,NA,PROGRESSION,NA,NA,NA
24,dfa9513d-4e09-405b-a80f-2987ec5c5263,TCGA.B8.4143,TCGA-B8-4143-D3365,a34a2429-50ce-49f6-af1a-62f0687ea43e,2010-11-16,INTERLEUKIN-2,NA,IMMUNOTHERAPY,133,FALSE,388,NA,NA,NA,NA,3,NA,NA,NA,NA,1,INTRAVENOUS,NA,NA,OTHER,METASTATIC DISEASE AT DIAGNOSIS,NA,NA
25,a22d5ba2-5f11-49e9-911a-ec03b785fae5,TCGA.B8.4153,TCGA-B8-4153-D12424,39f4d6f0-b29e-47cf-b96c-70750f2ab203,2011-6-1,PAZOPANIB,NA,CHEMOTHERAPY,238,TRUE,NA,NA,NA,NA,NA,1,NA,MG/DAY,NA,800,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
26,d62d39f9-c896-4758-a785-e236f0154f14,TCGA.B8.5162,TCGA-B8-5162-D17689,bce01735-34e1-4c81-bb08-874717ffcb86,2011-10-24,SUTENT,NA,CHEMOTHERAPY,-58,FALSE,-28,NA,NA,NA,NA,1,NA,MG/DAY,NA,50,1,ORAL,NA,NA,OTHER,NEOADJUVANT,NA,NA
27,d9f1bb02-4cb0-4f7c-8f34-ff5f301c6b2c,TCGA.BP.4161,TCGA-BP-4161-D9811,48e716eb-d25e-434b-b899-55440e1e28b6,2011-3-31,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,2752,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
28,3c1b6de7-c45f-4d86-be4b-a72ca7ca7cf9,TCGA.BP.4165,TCGA-BP-4165-D10780,9ef73876-67af-469e-90f8-430d1e6ff672,2011-4-26,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,2594,TRUE,NA,NA,NA,NA,NA,19,NA,NA,NA,NA,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
29,3f05a719-e81e-4f0c-a5c1-f1733b7aba11,TCGA.BP.4169,TCGA-BP-4169-D10867,bf4d4656-1142-462e-b4e5-aeb06fe70832,2011-4-28,AXITINIB,NA,TARGETED MOLECULAR THERAPY,127,FALSE,253,NA,NA,NA,NA,6,NA,NA,NA,NA,2,ORAL,NA,NA,PROGRESSION,NA,NA,NA
30,3f05a719-e81e-4f0c-a5c1-f1733b7aba11,TCGA.BP.4169,TCGA-BP-4169-D10866,eaa5273c-1fee-4fa9-9065-80dff2764426,2011-4-28,INTERFERON,NA,IMMUNOTHERAPY,36,FALSE,78,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,SUBCUTANEOUS,NA,NA,OTHER,METASTASIS,NA,NA
31,6ccabcd0-8f30-4828-851f-0ac7cee1a33f,TCGA.BP.4329,TCGA-BP-4329-D10883,45ddd952-faa4-459a-8e61-5ee2fbd2a071,2011-4-28,INTERFERON,NA,IMMUNOTHERAPY,190,FALSE,510,NA,NA,NA,NA,NA,NA,NA,NA,9e+06,1,SUBCUTANEOUS,NA,NA,OTHER,METASTASIS,NA,NA
32,6ccabcd0-8f30-4828-851f-0ac7cee1a33f,TCGA.BP.4329,TCGA-BP-4329-D10884,9bf6d9f2-4e1f-450d-938a-99f2ca551f6d,2011-4-28,TEMSIROLIMUS,NA,TARGETED MOLECULAR THERAPY,204,FALSE,510,NA,NA,NA,NA,NA,NA,MG,NA,15,1,INTRAVENOUS,NA,NA,OTHER,METASTASIS,NA,NA
33,e5eca191-f585-490d-81e3-9cced1047093,TCGA.BP.4334,TCGA-BP-4334-D10945,f1c101cf-ebc1-4e9f-b1d7-9e232a6703e1,2011-5-2,INTERFERON,NA,IMMUNOTHERAPY,520,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,6e+06,1,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
34,ed97aeee-2a5b-4361-ab4f-f53c3fc5f532,TCGA.BP.4335,TCGA-BP-4335-D10965,bb6c5138-3ac8-4e82-954f-554ed8e41733,2011-5-2,INTERFERON,NA,IMMUNOTHERAPY,42,FALSE,134,NA,NA,NA,NA,4,NA,MG/KG,NA,4.5,1,SUBCUTANEOUS,NA,NA,OTHER,METASTASIS,NA,NA
35,4978eb8d-4a38-470b-9a00-6dd3aada1aa9,TCGA.BP.4338,TCGA-BP-4338-D11006,7b83d49a-3f0b-40ec-a14a-4e0f51023c24,2011-5-2,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,1765,FALSE,2450,NA,NA,NA,NA,17,NA,MG,NA,50,1,ORAL,NA,NA,OTHER,METASTASIS,NA,NA
36,4978eb8d-4a38-470b-9a00-6dd3aada1aa9,TCGA.BP.4338,TCGA-BP-4338-D11015,187ebffd-f320-4e65-9abe-4622eb4d4edf,2011-5-2,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,2460,FALSE,2572,NA,NA,NA,NA,4,NA,MG,NA,400,2,ORAL,NA,NA,PROGRESSION,NA,NA,NA
37,4978eb8d-4a38-470b-9a00-6dd3aada1aa9,TCGA.BP.4338,TCGA-BP-4338-D11017,cb7f3030-e7de-4294-a627-6f083cd7db48,2011-5-2,EVEROLIMUS,NA,CHEMOTHERAPY,2586,TRUE,NA,NA,NA,NA,NA,9,NA,MG,NA,10,3,ORAL,NA,NA,PROGRESSION,NA,NA,NA
38,037c691e-6320-451b-9276-78459f1b705c,TCGA.BP.4352,TCGA-BP-4352-D11087,00ba7bc0-941c-421e-b252-a4520dfff776,2011-5-3,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,35,FALSE,59,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,ORAL,NA,NA,PALLIATIVE,NA,NA,NA
39,d9208e7b-0b47-43ff-a4e8-d4e591e286c4,TCGA.BP.4354,TCGA-BP-4354-D9699,6c38b574-14e5-4695-abe8-f6cb849dbbbf,2011-3-30,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,10,FALSE,454,NA,NA,NA,NA,11,NA,MG,NA,25,1,ORAL,NA,NA,OTHER,NEOADJUVANT,NA,NA
40,d9208e7b-0b47-43ff-a4e8-d4e591e286c4,TCGA.BP.4354,TCGA-BP-4354-D9703,bba9708b-8ae0-4cf6-b829-34d791507114,2011-3-30,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,595,FALSE,NA,NA,NA,NA,NA,NA,NA,MG,NA,200,4,ORAL,NA,NA,ADJUVANT,NA,NA,NA
41,d9208e7b-0b47-43ff-a4e8-d4e591e286c4,TCGA.BP.4354,TCGA-BP-4354-D9704,f671bce4-3fdd-4ead-a4d1-9c18c9202c37,2011-3-30,TEMSIROLIMUS,NA,TARGETED MOLECULAR THERAPY,721,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,INTRAVENOUS,NA,NA,OTHER,PATIENT CANNOT TOLERATE SORAFENIB,NA,NA
42,d9208e7b-0b47-43ff-a4e8-d4e591e286c4,TCGA.BP.4354,TCGA-BP-4354-D9701,3672a244-cace-4004-87c5-a99ea6db94db,2011-3-30,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,583,FALSE,589,NA,NA,NA,NA,1,NA,MG,NA,400,3,ORAL,NA,NA,PROGRESSION,NA,NA,NA
43,d9208e7b-0b47-43ff-a4e8-d4e591e286c4,TCGA.BP.4354,TCGA-BP-4354-D9700,f7b86ebd-d7e6-48f7-9409-d19f3255f60e,2011-3-30,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,490,FALSE,525,NA,NA,NA,NA,3,NA,MG,NA,25,2,ORAL,NA,NA,ADJUVANT,NA,NA,NA
44,d9208e7b-0b47-43ff-a4e8-d4e591e286c4,TCGA.BP.4354,TCGA-BP-4354-D9749,6c5d6738-1a45-445e-93cb-7724d8401079,2011-3-31,GEFITINIB,NA,TARGETED MOLECULAR THERAPY,10,FALSE,454,NA,NA,NA,NA,11,NA,NA,NA,NA,1,ORAL,NA,NA,OTHER,NEOADJUVANT,NA,NA
45,c3cc716b-1b9c-4e73-9a40-f1f891a17c2d,TCGA.BP.4770,TCGA-BP-4770-D11188,52c3f62f-beeb-4f58-b4e1-a829236a5240,2011-5-4,INTERFERON,NA,IMMUNOTHERAPY,211,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,5e+06,1,SUBCUTANEOUS,NA,NA,OTHER,METASTASIS,NA,NA
46,500636a5-d42b-469f-98e2-fdd4dddc61a0,TCGA.BP.4787,TCGA-BP-4787-D11359,6cde261d-db81-44f3-885d-a1202bb65401,2011-5-9,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,53,FALSE,333,NA,NA,NA,NA,7,NA,MG,NA,50,1,ORAL,NA,NA,OTHER,METASTASIS,NA,NA
47,500636a5-d42b-469f-98e2-fdd4dddc61a0,TCGA.BP.4787,TCGA-BP-4787-D11361,0fdec60b-14c1-443d-a7c6-b4f0f34159d0,2011-5-9,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,361,FALSE,388,NA,NA,NA,NA,1,NA,MG,NA,400,2,ORAL,NA,NA,PROGRESSION,NA,NA,NA
48,500636a5-d42b-469f-98e2-fdd4dddc61a0,TCGA.BP.4787,TCGA-BP-4787-D11362,4edfe557-3699-45c5-8a0f-a1c831dbc79a,2011-5-9,TEMSIROLIMUS,NA,CHEMOTHERAPY,412,FALSE,440,NA,NA,NA,NA,NA,NA,MG,NA,25,3,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
49,b81998f2-b3ff-4976-bc1c-8d38a68efa1d,TCGA.BP.4804,TCGA-BP-4804-D21225,fd535393-6afe-4ffb-bfd6-cb135562af1b,2012-2-7,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,1373,TRUE,NA,NA,NA,NA,NA,NA,NA,MG,NA,37.5,2,ORAL,NA,NA,OTHER,DOSE REDUCTION,NA,NA
50,b81998f2-b3ff-4976-bc1c-8d38a68efa1d,TCGA.BP.4804,TCGA-BP-4804-D21224,fa5ad7b2-aefb-4f88-b687-342abbb3c338,2012-2-7,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,1289,FALSE,1359,NA,NA,NA,NA,2,NA,MG,NA,50,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
51,d6625c4d-cd1c-4c62-8100-e8b2a49ce3ad,TCGA.BP.4974,TCGA-BP-4974-D9814,0c9ca688-dbc5-4768-a966-40b9c23f8d80,2011-3-31,GEFITINIB,NA,TARGETED MOLECULAR THERAPY,56,FALSE,59,NA,NA,NA,NA,1,NA,NA,NA,NA,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
52,d6625c4d-cd1c-4c62-8100-e8b2a49ce3ad,TCGA.BP.4974,TCGA-BP-4974-D9813,0ed85dba-57c4-4f24-b5c3-33cae30dc8de,2011-3-31,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,56,FALSE,58,NA,NA,NA,NA,1,NA,NA,NA,NA,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
53,d6625c4d-cd1c-4c62-8100-e8b2a49ce3ad,TCGA.BP.4974,TCGA-BP-4974-D9815,7439b55d-69e9-4010-bcb3-b051ac46c94d,2011-3-31,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,75,FALSE,155,NA,NA,NA,NA,NA,NA,MG,NA,50,2,ORAL,NA,NA,OTHER,RE-STARTED TREATMENT,NA,NA
54,d6625c4d-cd1c-4c62-8100-e8b2a49ce3ad,TCGA.BP.4974,TCGA-BP-4974-D9816,deb54796-0c89-40a5-a469-0ba39580ca2e,2011-3-31,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,178,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,ORAL,NA,NA,OTHER,NA,NA,NA
55,c285ada3-fd49-46a5-882f-b6c352572e2a,TCGA.BP.4985,TCGA-BP-4985-D11103,45bfa7b8-f1d7-46e6-ab48-70cfc7b66d4f,2011-5-2,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,307,FALSE,728,NA,NA,NA,NA,9,NA,MG,NA,50,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
56,57070e5b-0eb5-44b7-abb3-3007fa34543a,TCGA.BP.5009,TCGA-BP-5009-D9678,6e619ac0-1fae-4043-8203-45902fb4ce6f,2011-3-30,SUNITINIB,NA,CHEMOTHERAPY,338,FALSE,577,NA,NA,NA,NA,6,NA,MG,NA,50,1,ORAL,NA,NA,OTHER,RECURRENT AND METASTATIC,NA,NA
57,57070e5b-0eb5-44b7-abb3-3007fa34543a,TCGA.BP.5009,TCGA-BP-5009-D9680,62753c86-2bba-4018-ba2b-f1bde4e757c3,2011-3-30,EVEROLIMUS,NA,CHEMOTHERAPY,609,FALSE,1023,NA,NA,NA,NA,5,NA,MG,NA,10,2,ORAL,NA,NA,PROGRESSION,NA,NA,NA
58,57070e5b-0eb5-44b7-abb3-3007fa34543a,TCGA.BP.5009,TCGA-BP-5009-D9683,acadf3e7-76af-4657-bcb0-f8ff07e5d8c2,2011-3-30,PAZOPANIB,NA,TARGETED MOLECULAR THERAPY,1029,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,ORAL,NA,NA,OTHER,NA,NA,NA
59,57070e5b-0eb5-44b7-abb3-3007fa34543a,TCGA.BP.5009,TCGA-BP-5009-D9681,418f9d32-3c0b-417a-a008-81977b4be13d,2011-3-30,BEVACIZUMAB,NA,CHEMOTHERAPY,765,FALSE,765,NA,NA,NA,NA,1,NA,MG,NA,800,3,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
60,6e9e5e05-2bf8-4724-8e31-241f517289de,TCGA.BP.5178,TCGA-BP-5178-D9760,6165a14b-241a-45c4-bbe9-6e5191d3e232,2011-3-31,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,407,FALSE,772,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,ORAL,NA,NA,PROGRESSION,NA,NA,NA
61,23c7555b-7a37-415d-bda8-3588078a0c2e,TCGA.BP.5189,TCGA-BP-5189-D9666,9540f223-bc67-458e-8ae1-e8de7f543e1c,2011-3-30,TEMSIROLIMUS,NA,TARGETED MOLECULAR THERAPY,661,FALSE,773,NA,NA,NA,NA,NA,NA,MG,NA,25,1,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
62,23c7555b-7a37-415d-bda8-3588078a0c2e,TCGA.BP.5189,TCGA-BP-5189-D9667,effb694d-5c1a-44b8-a266-0d03ce5354f4,2011-3-30,BEVACIZUMAB,NA,CHEMOTHERAPY,794,FALSE,794,NA,NA,NA,NA,1,NA,NA,NA,NA,2,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
63,54c9850c-9b67-42ea-a04b-16a88f786dfa,TCGA.BP.5201,TCGA-BP-5201-D9676,51a5697f-1fa8-410c-9d4b-f7596084fd9f,2011-3-30,INTERLEUKIN-2,NA,IMMUNOTHERAPY,469,FALSE,603,NA,NA,NA,NA,2,NA,NA,NA,NA,1,NA,NA,NA,PROGRESSION,NA,NA,NA
64,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D6633,a2b45ec6-a9e8-4e6e-b316-cd86e3db9123,2011-1-24,TEMSIROLIMUS,NA,CHEMOTHERAPY,47,FALSE,476,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
65,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9507,7d759b39-3ca8-4087-84f1-45f030189eac,2011-3-24,BORTEZOMIB,NA,TARGETED MOLECULAR THERAPY,1476,FALSE,1742,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
66,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9506,e72b6d1a-b943-4cd7-9915-382face7ca16,2011-3-25,PAZOPANIB,NA,TARGETED MOLECULAR THERAPY,1962,FALSE,2053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
67,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9501,94cf2cda-aca4-49a9-b311-bfa9cf70196a,2011-3-25,SUTENT,NA,CHEMOTHERAPY,512,FALSE,816,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
68,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9504,54419681-f557-4d4d-8a03-a2dc7482a7d0,2011-3-25,AVASTIN,NA,TARGETED MOLECULAR THERAPY,1868,FALSE,1883,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
69,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9503,43b4785b-3f0f-4184-be86-dacff571cf29,2011-3-25,NAB-RAPAMYCIN,NA,TARGETED MOLECULAR THERAPY,1213,FALSE,1468,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
70,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9499,191125ca-4520-483c-b644-25d9065e0a1c,2011-3-25,ROFERON-A,NA,CHEMOTHERAPY,51,FALSE,476,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
71,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9500,afce5403-0ffb-4b19-82a9-c8132d2d406a,2011-3-25,INTRON A,NA,CHEMOTHERAPY,484,FALSE,507,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
72,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9502,6fe89f3d-273f-4de3-9f20-bd7ed30440a4,2011-3-25,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,849,FALSE,861,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
73,772e3aed-f211-42a1-9ab2-1c543f581541,TCGA.CJ.4637,TCGA-CJ-4637-D9505,1ec9011a-b889-47c0-a845-6af51b872a8f,2011-3-25,AZD,NA,TARGETED MOLECULAR THERAPY,1868,FALSE,1888,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
74,06197e26-3cb0-4bd0-a6e8-dd9af5047c6a,TCGA.CJ.4638,TCGA-CJ-4638-D6635,a35ff921-80b8-4e3f-8530-b47b5a68224c,2011-1-24,GEMICTIABINE,NA,CHEMOTHERAPY,70,FALSE,160,NA,NA,NA,NA,5,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
75,06197e26-3cb0-4bd0-a6e8-dd9af5047c6a,TCGA.CJ.4638,TCGA-CJ-4638-D9421,331065f1-e997-4f48-b80d-594232107917,2011-3-23,AVASTIN,NA,CHEMOTHERAPY,252,FALSE,281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
76,06197e26-3cb0-4bd0-a6e8-dd9af5047c6a,TCGA.CJ.4638,TCGA-CJ-4638-D9419,0f9a0801-21be-4181-af14-88aeee0f9eaa,2011-3-23,5-FLUOROURACIL,NA,CHEMOTHERAPY,70,FALSE,252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
77,06197e26-3cb0-4bd0-a6e8-dd9af5047c6a,TCGA.CJ.4638,TCGA-CJ-4638-D9420,9bc6a537-f896-4571-b090-aa5369b2fdc7,2011-3-23,INTERLEUKIN-2,NA,CHEMOTHERAPY,192,FALSE,221,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
78,cdfa3c5d-2fe8-4dfd-92c2-a54f39f55f18,TCGA.CJ.4641,TCGA-CJ-4641-D6637,e62a1180-3ebc-4f8b-83bb-351a04aaef97,2011-1-24,ONCOPHAGE,NA,IMMUNOTHERAPY,37,FALSE,321,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
79,8fd493c5-1375-4f76-b337-c9a75e3abdbe,TCGA.CJ.4644,TCGA-CJ-4644-D9532,b746fd6f-9a10-4c50-936e-541564bcd151,2011-3-25,TARCEVA,NA,TARGETED MOLECULAR THERAPY,229,FALSE,316,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,ORAL,NA,NA,PROGRESSION,NA,NA,NA
80,8fd493c5-1375-4f76-b337-c9a75e3abdbe,TCGA.CJ.4644,TCGA-CJ-4644-D9530,7171cb82-3852-4fe2-bac7-14c6a3ab38aa,2011-3-25,AVASTIN,NA,TARGETED MOLECULAR THERAPY,229,FALSE,316,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
81,8fd493c5-1375-4f76-b337-c9a75e3abdbe,TCGA.CJ.4644,TCGA-CJ-4644-D9529,7d5cbe9b-e974-4f19-8878-6a0ba7996e82,2011-3-25,ONCOPHAGE,NA,OTHER, SPECIFY IN NOTES,27,FALSE,229,NA,NA,NA,NA,NA,VACCINE,NA,NA,NA,1,INTRAMUSCULAR,NA,NA,PROGRESSION,NA,NA,NA
82,8fd493c5-1375-4f76-b337-c9a75e3abdbe,TCGA.CJ.4644,TCGA-CJ-4644-D10750,c9a68985-cd93-423c-87f0-5c0871107e5d,2011-4-25,CAPECITABINE,NA,CHEMOTHERAPY,150,FALSE,222,NA,NA,NA,NA,NA,NA,G/DAY,NA,2.5,2,ORAL,NA,NA,PROGRESSION,NA,NA,NA
83,8fd493c5-1375-4f76-b337-c9a75e3abdbe,TCGA.CJ.4644,TCGA-CJ-4644-D10749,48df2010-d4bd-4b71-af35-008ff98b2aea,2011-4-25,INTRON A,NA,IMMUNOTHERAPY,162,FALSE,222,NA,NA,NA,NA,1,NA,NA,NA,NA,2,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
84,2309c424-26fa-4cc6-a22a-2dc0f989af59,TCGA.CJ.4868,TCGA-CJ-4868-D6854,42b8804d-3c4c-465e-af76-6758e70bad3c,2011-1-28,PROLEUKIN,NA,IMMUNOTHERAPY,56,FALSE,89,NA,NA,NA,NA,2,NA,NA,NA,NA,1,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
85,2309c424-26fa-4cc6-a22a-2dc0f989af59,TCGA.CJ.4868,TCGA-CJ-4868-D9079,0391be00-8514-4e2b-b975-bc795d2fcf45,2011-3-13,GEMCITABINE,NA,CHEMOTHERAPY,296,FALSE,365,NA,NA,NA,NA,3,NA,NA,NA,NA,3,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
86,2309c424-26fa-4cc6-a22a-2dc0f989af59,TCGA.CJ.4868,TCGA-CJ-4868-D9080,ee8e56ec-9936-46f8-aeb1-a67088026892,2011-3-13,NEXAVAR,NA,TARGETED MOLECULAR THERAPY,379,FALSE,534,NA,NA,NA,NA,1,NA,NA,NA,NA,4,ORAL,NA,NA,PROGRESSION,NA,NA,NA
87,2309c424-26fa-4cc6-a22a-2dc0f989af59,TCGA.CJ.4868,TCGA-CJ-4868-D9078,47b7c613-8b63-4efc-8097-7f759a60240d,2011-3-13,AVASTIN,NA,TARGETED MOLECULAR THERAPY,135,FALSE,282,NA,NA,NA,NA,10,NA,NA,NA,NA,2,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
88,2309c424-26fa-4cc6-a22a-2dc0f989af59,TCGA.CJ.4868,TCGA-CJ-4868-D9513,11d4be47-87a8-4f0e-9466-a404b93acfb7,2011-3-25,CAPECITABIN,NA,CHEMOTHERAPY,296,FALSE,365,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,ORAL,NA,NA,PROGRESSION,NA,NA,NA
89,2309c424-26fa-4cc6-a22a-2dc0f989af59,TCGA.CJ.4868,TCGA-CJ-4868-D9517,8ed04635-5953-4258-85d0-a984c7a3ac4c,2011-3-25,TARCEVA,NA,TARGETED MOLECULAR THERAPY,114,FALSE,288,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
90,06d86d68-0fd5-4c6e-8783-ed732a3291e8,TCGA.CJ.4869,TCGA-CJ-4869-D7278,5b6b47ff-9927-47ce-9709-808915090758,2011-2-8,NEXAVAAR,NA,TARGETED MOLECULAR THERAPY,767,FALSE,854,NA,NA,NA,NA,NA,SORAFENIB,NA,NA,NA,NA,ORAL,NA,NA,RECURRENCE,NA,NA,NA
91,06d86d68-0fd5-4c6e-8783-ed732a3291e8,TCGA.CJ.4869,TCGA-CJ-4869-D7279,8941a2e3-132e-40a4-85f2-416e15dd6e44,2011-2-8,SUTENT,NA,TARGETED MOLECULAR THERAPY,881,FALSE,1963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,RECURRENCE,NA,NA,NA
92,dbe16232-525e-4101-9a39-9d4323b10ee9,TCGA.CJ.4871,TCGA-CJ-4871-D6855,81044ef3-a822-4e52-a82a-895cacf8a4d7,2011-1-28,ALPHA INTERFERON,NA,IMMUNOTHERAPY,98,TRUE,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,1,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
93,818022ea-123e-438d-9671-542f479028f2,TCGA.CJ.4875,TCGA-CJ-4875-D6857,3575a7d6-f94c-42a0-8cc3-1ab64eaee621,2011-1-28,NEXAVAR,NA,TARGETED MOLECULAR THERAPY,1083,TRUE,NA,NA,NA,NA,NA,36,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
94,24c1cf70-bd67-431e-a623-d20f8d3f52b2,TCGA.CJ.4881,TCGA-CJ-4881-D6858,78b17dac-e678-491b-97fa-ab8b7c3bcd57,2011-1-28,TEMSIROLIMUS,NA,TARGETED MOLECULAR THERAPY,1931,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,INTRAVENOUS,NA,NA,RECURRENCE,NA,NA,NA
95,c4bbbcd2-aa18-4b1f-99d4-93279e31d7e7,TCGA.CJ.4887,TCGA-CJ-4887-D6859,9a7f9dd4-d130-46e4-9171-0a24cb30b914,2011-1-28,ONCOPHAGE,NA,IMMUNOTHERAPY,34,FALSE,124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,OTHER,NA,NA,NA
96,f2fca062-ca87-4089-916d-49b9ff146797,TCGA.CJ.4888,TCGA-CJ-4888-D6860,f7000bb0-6264-451a-bdf1-3561c7f81464,2011-1-28,SUTENT,NA,TARGETED MOLECULAR THERAPY,576,FALSE,1456,NA,NA,NA,NA,36,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
97,46d34d0c-b8a2-4ebd-b9a0-5485904ecafa,TCGA.CJ.4890,TCGA-CJ-4890-D6861,388898f3-bb79-4469-aaa0-39327882283c,2011-1-28,INTERFERON,NA,IMMUNOTHERAPY,70,FALSE,211,NA,NA,NA,NA,4,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
98,46d34d0c-b8a2-4ebd-b9a0-5485904ecafa,TCGA.CJ.4890,TCGA-CJ-4890-D9952,5442b568-0b8a-4115-8b6d-977e5df77929,2011-4-4,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,263,FALSE,444,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
99,46d34d0c-b8a2-4ebd-b9a0-5485904ecafa,TCGA.CJ.4890,TCGA-CJ-4890-D9953,0978afe3-0801-4e3a-a499-1f9b4aa63be9,2011-4-4,TIPIFARNIB,NA,TARGETED MOLECULAR THERAPY,263,FALSE,444,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
100,46d34d0c-b8a2-4ebd-b9a0-5485904ecafa,TCGA.CJ.4890,TCGA-CJ-4890-D9959,e38d0bef-e746-47e6-a0bc-762fdc1919be,2011-4-4,NEXAVAR,NA,TARGETED MOLECULAR THERAPY,1483,FALSE,1636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
101,46d34d0c-b8a2-4ebd-b9a0-5485904ecafa,TCGA.CJ.4890,TCGA-CJ-4890-D9961,e1b40910-8c57-4eda-86a4-5f9508be8fba,2011-4-4,AFINITOR,NA,TARGETED MOLECULAR THERAPY,1636,FALSE,1698,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
102,46d34d0c-b8a2-4ebd-b9a0-5485904ecafa,TCGA.CJ.4890,TCGA-CJ-4890-D9956,5916d249-20d8-420a-bd3f-ee16a03ca70d,2011-4-4,SUTENT,NA,TARGETED MOLECULAR THERAPY,480,FALSE,1483,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
103,d1e4f4c0-08cc-4012-9372-9ab987d80dab,TCGA.CJ.4894,TCGA-CJ-4894-D6863,a73eac24-7748-4b45-adba-a6bcf5bdce9c,2011-1-28,INTERFERON,NA,IMMUNOTHERAPY,188,FALSE,240,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,RECURRENCE,NA,NA,NA
104,b7994839-77a5-4725-aa58-a9e8c79dbfc2,TCGA.CJ.4895,TCGA-CJ-4895-D6867,9254b0a1-4315-4018-9448-1f18c5680998,2011-1-28,TARCEVA,NA,TARGETED MOLECULAR THERAPY,45,FALSE,228,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
105,b7994839-77a5-4725-aa58-a9e8c79dbfc2,TCGA.CJ.4895,TCGA-CJ-4895-D9288,7c8e6a67-e0f7-400b-9bd9-9acda09df66c,2011-3-17,GEMZAR,NA,CHEMOTHERAPY,255,FALSE,740,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
106,b7994839-77a5-4725-aa58-a9e8c79dbfc2,TCGA.CJ.4895,TCGA-CJ-4895-D9290,b59b9c89-24a8-40fc-b23f-e050c4132812,2011-3-17,XELODA,NA,CHEMOTHERAPY,255,FALSE,740,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
107,b7994839-77a5-4725-aa58-a9e8c79dbfc2,TCGA.CJ.4895,TCGA-CJ-4895-D9286,075290aa-7d9e-4f3b-97ee-e3d43f71dc67,2011-3-17,AVASTIN,NA,TARGETED MOLECULAR THERAPY,45,FALSE,559,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
108,33cd8b05-2b9b-40dd-97a2-40d02e27ee90,TCGA.CJ.4900,TCGA-CJ-4900-D6866,4b92ab24-0a69-42aa-8f86-5ed57a8df17e,2011-1-29,TARCEVA,NA,TARGETED MOLECULAR THERAPY,-92,FALSE,0,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,ORAL,NA,NA,OTHER,NEO-ADJUVANT,NA,NA
109,33cd8b05-2b9b-40dd-97a2-40d02e27ee90,TCGA.CJ.4900,TCGA-CJ-4900-D9257,ed2146fb-1aab-4d45-bad3-c656a4aa11b0,2011-3-16,AVASTIN,NA,TARGETED MOLECULAR THERAPY,-92,FALSE,0,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,OTHER,NEO-ADJUVANT,NA,NA
110,ec3b2a30-fcf6-45ef-bd9d-e6089a237c0f,TCGA.CJ.4904,TCGA-CJ-4904-D7281,82b2af25-4930-4748-b53a-cd1ab7fd3097,2011-2-8,NEXAVAR,NA,TARGETED MOLECULAR THERAPY,295,FALSE,463,NA,NA,NA,NA,4,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
111,f48fc7d5-ca35-4fdf-8150-0ce34f0f6b3e,TCGA.CJ.4913,TCGA-CJ-4913-D7284,c1a1fbd4-8cac-48d7-a3d4-ffe8223e52b9,2011-2-8,SUTENT,NA,TARGETED MOLECULAR THERAPY,861,FALSE,1020,NA,NA,NA,NA,4,NA,NA,NA,NA,NA,ORAL,NA,NA,RECURRENCE,NA,NA,NA
112,267ff78b-bceb-466e-8582-c560fe227ff0,TCGA.CJ.4918,TCGA-CJ-4918-D7290,7cb2bbac-c189-47ae-a6ce-0812f685b88b,2011-2-8,GEMCITABINE,NA,CHEMOTHERAPY,36,FALSE,45,NA,NA,NA,NA,1,NA,NA,NA,NA,1,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
113,25131445-d3cf-46af-b3c5-ca1d1e3561bb,TCGA.CJ.4923,TCGA-CJ-4923-D7292,1b952d0c-b125-40d0-a5ff-1193c55e8313,2011-2-8,PROLEUKIN (IL-2),NA,IMMUNOTHERAPY,192,FALSE,379,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
114,310c31bf-91ce-40b4-99e4-a10242296de9,TCGA.CJ.5676,TCGA-CJ-5676-D10768,42bca1a1-845d-44ba-85e9-b6cb7e3fffad,2011-4-26,ONCOPHAGE VACCINE,NA,OTHER, SPECIFY IN NOTES,69,FALSE,209,NA,NA,NA,NA,13,VACCINE,NA,NA,NA,1,SUBCUTANEOUS,NA,NA,ADJUVANT,NA,NA,NA
115,310c31bf-91ce-40b4-99e4-a10242296de9,TCGA.CJ.5676,TCGA-CJ-5676-D10782,7a7b6d14-0d90-436b-9fe0-d65d3bf9a162,2011-4-26,PAZOPANIB,NA,TARGETED MOLECULAR THERAPY,2227,TRUE,NA,NA,NA,NA,NA,NA,NA,MG/KG/DAY,NA,800,2,ORAL,NA,NA,RECURRENCE,NA,NA,NA
116,d2664fde-ce3b-45e6-9a23-4a07980f7bac,TCGA.CJ.5677,TCGA-CJ-5677-D10784,fba74882-fb5f-43f2-8edd-945f9ed59003,2011-4-26,INTERFERON-ALPHA,NA,IMMUNOTHERAPY,42,FALSE,70,NA,NA,NA,NA,2,NA,NA,NA,2,2,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
117,d2664fde-ce3b-45e6-9a23-4a07980f7bac,TCGA.CJ.5677,TCGA-CJ-5677-D10783,96ff23fe-4534-42bf-af6f-e7d81301737f,2011-4-26,XELODA,NA,CHEMOTHERAPY,42,FALSE,70,NA,NA,NA,NA,2,NA,G/M2,G/DAY,1,1,ORAL,NA,NA,PROGRESSION,NA,2,NA
118,d2664fde-ce3b-45e6-9a23-4a07980f7bac,TCGA.CJ.5677,TCGA-CJ-5677-D10785,795bcad0-cfa4-4568-9726-bba045ea3853,2011-4-26,GEMCITABINE,NA,CHEMOTHERAPY,70,FALSE,378,NA,NA,NA,NA,5,NA,MG/M2,NA,600,3,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
119,822cf6c1-dd65-4814-94b1-0c335208ad9b,TCGA.CJ.5678,TCGA-CJ-5678-D10850,e9fb1132-a565-44ed-a4d2-4117f1666ee4,2011-4-28,ONCOPHAGE VACCINE,NA,OTHER, SPECIFY IN NOTES,43,FALSE,93,NA,NA,NA,NA,6,NA,ML,NA,0.2,1,SUBCUTANEOUS,NA,NA,ADJUVANT,NA,NA,NA
120,3fa6c93e-e7fe-402c-9526-c81411aa0920,TCGA.CJ.5679,TCGA-CJ-5679-D10851,02a170ea-b4b2-42e7-840f-cc589ab99671,2011-4-28,INTERFERON-ALPHA,NA,IMMUNOTHERAPY,116,FALSE,274,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
121,3fa6c93e-e7fe-402c-9526-c81411aa0920,TCGA.CJ.5679,TCGA-CJ-5679-D10856,ea807644-32c7-48bd-b2e8-1cbd56f6b3cf,2011-4-28,THALIDOMIDE,NA,CHEMOTHERAPY,547,FALSE,599,NA,NA,NA,NA,NA,NA,MG/DAY,NA,100,5,ORAL,NA,NA,PROGRESSION,NA,NA,NA
122,3fa6c93e-e7fe-402c-9526-c81411aa0920,TCGA.CJ.5679,TCGA-CJ-5679-D10855,ffd8b92a-6b6b-4cca-bf82-9e943e3237d9,2011-4-28,AVASTIN,NA,TARGETED MOLECULAR THERAPY,344,FALSE,547,NA,NA,NA,NA,16,NA,MG/KG,NA,10,4,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
123,3fa6c93e-e7fe-402c-9526-c81411aa0920,TCGA.CJ.5679,TCGA-CJ-5679-D10852,af2a8ba4-39b6-4e03-ac73-85be416132d1,2011-4-28,GEMCITABINE,NA,CHEMOTHERAPY,274,FALSE,344,NA,NA,NA,NA,3,NA,MG/M2,MG/WK,1000,2,INTRAVENOUS,NA,NA,PROGRESSION,NA,1970,NA
124,3fa6c93e-e7fe-402c-9526-c81411aa0920,TCGA.CJ.5679,TCGA-CJ-5679-D10853,f4bd6ee0-f8e7-4eba-9a5b-164cd3208007,2011-4-29,XELODA,NA,CHEMOTHERAPY,274,FALSE,344,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
125,5db69ebe-38db-4ef3-b825-674b4a6ddaee,TCGA.CJ.5680,TCGA-CJ-5680-D10871,67fa6309-b5ad-4f62-a60e-adc3304e2632,2011-4-28,IL-2,NA,IMMUNOTHERAPY,220,FALSE,247,NA,NA,NA,NA,15,NA,NA,NA,NA,2,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
126,5db69ebe-38db-4ef3-b825-674b4a6ddaee,TCGA.CJ.5680,TCGA-CJ-5680-D10874,604063dd-ab5f-4ad4-aa71-072f8af66077,2011-4-28,AVASTIN,NA,TARGETED MOLECULAR THERAPY,275,FALSE,616,NA,NA,NA,NA,24,NA,MG/KG,NA,10,3,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
127,5db69ebe-38db-4ef3-b825-674b4a6ddaee,TCGA.CJ.5680,TCGA-CJ-5680-D10857,852a6313-ee15-421c-9683-e3b07d970f1d,2011-4-28,ONCOPHAGE VACCINE,NA,IMMUNOTHERAPY,53,FALSE,186,NA,NA,NA,NA,12,NA,ML,ML,0.2,1,SUBCUTANEOUS,NA,NA,ADJUVANT,NA,2.4,NA
128,5db69ebe-38db-4ef3-b825-674b4a6ddaee,TCGA.CJ.5680,TCGA-CJ-5680-D12649,a694a74a-e10e-4276-96b5-4d17abfb4681,2011-6-5,TARCEVA,NA,TARGETED MOLECULAR THERAPY,466,FALSE,629,NA,NA,NA,NA,1,NA,MG/DAY,NA,150,4,ORAL,NA,NA,PROGRESSION,NA,NA,NA
129,2939c03a-6f3f-4f7b-b246-34361baadeb9,TCGA.CJ.5681,TCGA-CJ-5681-D10876,fd23322f-f22f-47b9-b46b-55f1031aa4a9,2011-4-28,GEMCITABINE,NA,CHEMOTHERAPY,165,FALSE,235,NA,NA,NA,NA,3,NA,MG/KG,NA,10,2,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
130,2939c03a-6f3f-4f7b-b246-34361baadeb9,TCGA.CJ.5681,TCGA-CJ-5681-D10875,b54c8012-1258-4b9b-8bbb-3899e82aa8e8,2011-4-28,IL-2,NA,IMMUNOTHERAPY,105,FALSE,135,NA,NA,NA,NA,2,NA,NA,NA,NA,1,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
131,2939c03a-6f3f-4f7b-b246-34361baadeb9,TCGA.CJ.5681,TCGA-CJ-5681-D10877,d870b922-3cc1-4273-8cb7-aef6b75eaa13,2011-4-28,AVASTIN,NA,TARGETED MOLECULAR THERAPY,235,FALSE,318,NA,NA,NA,NA,4,NA,MG/KG,NA,650,3,INTRAVENOUS,NA,NA,PROGRESSION,NA,NA,NA
132,2939c03a-6f3f-4f7b-b246-34361baadeb9,TCGA.CJ.5681,TCGA-CJ-5681-D10878,24d2fd79-c834-49b6-bb48-616a5f935835,2011-4-28,RAD001,NA,TARGETED MOLECULAR THERAPY,305,FALSE,365,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,ORAL,NA,NA,PROGRESSION,NA,NA,NA
133,4c325ee1-9b8e-45d4-a0a7-e47ec1eac402,TCGA.CJ.5682,TCGA-CJ-5682-D10879,6ac833df-b07a-4a38-8395-f41b36572b14,2011-4-28,INTERFERON ALPHA,NA,IMMUNOTHERAPY,68,FALSE,813,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
134,2890b330-8ba5-4031-bed5-13e9d1d75af9,TCGA.CJ.6028,TCGA-CJ-6028-D14112,efec152d-14e5-41dc-93aa-d91112f20a91,2011-7-21,GEMCITABINE,NA,CHEMOTHERAPY,392,FALSE,903,NA,NA,NA,NA,2,NA,MG/M2,NA,600,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
135,2890b330-8ba5-4031-bed5-13e9d1d75af9,TCGA.CJ.6028,TCGA-CJ-6028-D14113,575516b7-e4d4-44f7-ba47-2853ce7409ee,2011-7-21,XELODA,NA,CHEMOTHERAPY,392,FALSE,903,NA,NA,NA,NA,2,NA,MG/M2/DAY,NA,1500,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
136,2890b330-8ba5-4031-bed5-13e9d1d75af9,TCGA.CJ.6028,TCGA-CJ-6028-D14115,8cc18e98-54bc-4edb-aed9-fa4d69f9c5bb,2011-7-21,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,1033,FALSE,1625,NA,NA,NA,NA,NA,NA,MG/DAY,NA,400,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
137,2890b330-8ba5-4031-bed5-13e9d1d75af9,TCGA.CJ.6028,TCGA-CJ-6028-D14100,a4e4b7e8-5549-4cbe-a05b-ddccae7c87e3,2011-7-21,ONCOPHAGE,NA,OTHER, SPECIFY IN NOTES,41,FALSE,130,NA,NA,NA,NA,NA,VACCINE,ML,ML,0.4,NA,SUBCUTANEOUS,NA,NA,OTHER,TREATMENT OF METASTATIC DISEASE FOLLOWING CYTOREDUCTIVE NEPHRECTOMY,3.6,NA
138,2890b330-8ba5-4031-bed5-13e9d1d75af9,TCGA.CJ.6028,TCGA-CJ-6028-D14114,9f0055bf-dd02-48b4-a681-cfa9fd95322c,2011-7-21,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,903,FALSE,1033,NA,NA,NA,NA,NA,NA,NA,MG/DAY,NA,NA,ORAL,NA,NA,PROGRESSION,NA,50,NA
139,2890b330-8ba5-4031-bed5-13e9d1d75af9,TCGA.CJ.6028,TCGA-CJ-6028-D14102,d0ce80e2-94c1-40bd-90aa-386450af25c2,2011-7-21,INTERFERON,NA,IMMUNOTHERAPY,336,FALSE,392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
140,4edff57f-4b0e-4770-beac-590da7d7232c,TCGA.CJ.6033,TCGA-CJ-6033-D16327,6c623ee3-2d55-46d5-ae7d-9347dd0a4752,2011-8-16,XELODA,NA,CHEMOTHERAPY,32,FALSE,74,NA,NA,NA,NA,2,NA,MG/DAY,NA,2500,NA,ORAL,NA,NA,OTHER,TREATMENT OF METASTATIC DISEASE FOLLOWING CYTOREDUCTIVE NEPHRECTOMY,NA,NA
141,4edff57f-4b0e-4770-beac-590da7d7232c,TCGA.CJ.6033,TCGA-CJ-6033-D16330,1a8e76f1-de11-4c9b-96d3-71a05c0e2f39,2011-9-16,INTERFERON,NA,IMMUNOTHERAPY,144,FALSE,172,NA,NA,NA,NA,NA,NA,NA,NA,5e+05,NA,SUBCUTANEOUS,NA,NA,PROGRESSION,NA,NA,NA
142,4edff57f-4b0e-4770-beac-590da7d7232c,TCGA.CJ.6033,TCGA-CJ-6033-D16329,71a0a459-12f4-4fca-bb66-42ce0f871f34,2011-9-16,IRESSA,NA,TARGETED MOLECULAR THERAPY,74,FALSE,144,NA,NA,NA,NA,NA,NA,MG/DAY,NA,250,NA,ORAL,NA,NA,OTHER,METISTATIC DISEASE,NA,NA
143,4edff57f-4b0e-4770-beac-590da7d7232c,TCGA.CJ.6033,TCGA-CJ-6033-D16328,4f5e45e8-f08e-4def-a405-7c6128d41653,2011-9-16,AVASTIN,NA,TARGETED MOLECULAR THERAPY,81,FALSE,144,NA,NA,NA,NA,NA,NA,MG/KG,NA,10,NA,INTRAVENOUS,NA,NA,OTHER,METISTATIC DISEASE,NA,NA
144,4edff57f-4b0e-4770-beac-590da7d7232c,TCGA.CJ.6033,TCGA-CJ-6033-D16326,361f2192-be38-459e-919f-e7fcd6f19a6b,2011-9-16,GEMCITABINE,NA,CHEMOTHERAPY,32,FALSE,74,NA,NA,NA,NA,2,NA,MG/M2/DAY,NA,600,NA,INTRAVENOUS,NA,NA,OTHER,TREATMENT OF METASTATIC DISEASE FOLLOWING CYTOREDUCTIVE NEPHRECTOMY,NA,NA
145,88fc4bc4-32cf-4d92-8c29-20d920b8f719,TCGA.CW.5580,TCGA-CW-5580-D8584,b1ebaccd-72cc-42a8-9286-50085222d185,2011-3-1,IFN-ALPHA (INTRON),NA,IMMUNOTHERAPY,50,FALSE,57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
146,0487fc41-386c-4d76-9084-daf959bf5e98,TCGA.CW.5585,TCGA-CW-5585-D8594,9adc6edd-2e8a-41ce-a364-51a4b140feaa,2011-3-1,SUTENT (SUNITINIB),NA,TARGETED MOLECULAR THERAPY,2563,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
147,9fd9104b-a26d-44c7-bb45-f1edd76d0aa0,TCGA.CW.5590,TCGA-CW-5590-D8614,1ca0a85b-5ae1-4a31-b005-c1fcf6d6520c,2011-3-1,SUTENT (SUNITINIB),NA,OTHER, SPECIFY IN NOTES,229,FALSE,956,NA,NA,NA,NA,NA,SU011248,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
148,f1ae0181-74f8-47fd-83be-83a7d01101cc,TCGA.CW.5591,TCGA-CW-5591-D8621,ecc5564d-d0e9-4b6a-9377-90a001040e2c,2011-3-1,IL-2 (HIGH DOSE),NA,IMMUNOTHERAPY,78,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149,5f53ace3-14ca-412a-af6c-98d8996f8177,TCGA.CW.6097,TCGA-CW-6097-D12249,f98c52fa-e5ad-4e18-ba98-dd31d1b92347,2011-5-26,BAY-439006,NA,OTHER, SPECIFY IN NOTES,115,FALSE,NA,NA,NA,NA,NA,NA,CLINICAL TRIAL,NA,NA,NA,NA,NA,NA,NA,PROGRESSION,NA,NA,NA
150,d5213422-9447-4f62-b486-3303e3f991fa,TCGA.CZ.4857,TCGA-CZ-4857-D7709,95cecfe0-ba80-4008-866f-7174a86b8bf5,2011-2-14,IL-2 THERAPY (INTERLEUKIN),NA,OTHER, SPECIFY IN NOTES,228,FALSE,247,NA,NA,NA,NA,1,BIOLOGICAL THERAPY,[IU]/KG,[IU]/KG,NA,NA,INTRAVENOUS,NA,NA,NA,NA,1177,NA
151,f06bdea2-4528-4a14-9cea-280af6b4c702,TCGA.CZ.4858,TCGA-CZ-4858-D7716,6e51f78f-a493-4217-a249-35ddd5602891,2011-2-14,INTERLEUKIN 2-HIGH DOSE,NA,OTHER, SPECIFY IN NOTES,1694,FALSE,1715,NA,NA,NA,NA,2,BIOLOGICAL THERAPY,[IU]/KG,[IU]/KG,600,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,1360,NA
152,6949efc1-4f71-4141-b129-a54b4bde5d2f,TCGA.CZ.4860,TCGA-CZ-4860-D7726,b9f157fa-713b-4fb9-b671-f5f15b0f1bac,2011-2-14,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,53,FALSE,132,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
153,226ce515-c12c-4195-bb5d-d6df2e135ff6,TCGA.CZ.4861,TCGA-CZ-4861-D20605,689f0d94-bd0a-4fc4-a67a-046aa3514ef9,2012-1-18,SORAFENIB - NEXAVAR,NA,TARGETED MOLECULAR THERAPY,-43,FALSE,32,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,ORAL,NA,NA,OTHER,NEOADJUVANT,NA,NA
154,f2801b21-5444-4cc3-a642-c60c6d82cd3d,TCGA.CZ.5454,TCGA-CZ-5454-D8994,e9789b15-22f2-4464-98f1-4cf7ecbe2e15,2011-3-10,SUTENT (SUNITINIB),NA,TARGETED MOLECULAR THERAPY,37,FALSE,324,NA,NA,NA,NA,7,NA,MG/DAY,MG,37.5,NA,ORAL,NA,NA,PROGRESSION,NA,8925,NA
155,467bf226-a646-4217-bce6-8d0f11c756eb,TCGA.CZ.5456,TCGA-CZ-5456-D9019,164714d6-5bec-464c-885c-4d81682616cd,2011-3-11,PAZOPANIB,NA,TARGETED MOLECULAR THERAPY,1124,FALSE,1286,NA,NA,NA,NA,4,NA,MG,NA,800,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
156,a7ddd737-714d-423f-8fb5-5a932d014487,TCGA.CZ.5460,TCGA-CZ-5460-D9029,f2fe44fb-e4b3-4b41-8fbd-6c99c5b15dfa,2011-3-11,INTERLEUKIN-2,NA,OTHER, SPECIFY IN NOTES,174,FALSE,298,NA,NA,NA,NA,2,BIOLOGICAL THERAPY,[IU]/KG,[IU]/KG,NA,NA,INTRAVENOUS,NA,NA,PROGRESSION,NA,2138,NA
157,393abcf7-1155-4b32-85ca-cd44d259e4b4,TCGA.CZ.5461,TCGA-CZ-5461-D9042,ad2f500b-aa23-44fe-86c6-2c45706d2065,2011-3-11,SUNITINIB (SUTENT),NA,TARGETED MOLECULAR THERAPY,45,FALSE,278,NA,NA,NA,NA,5,NA,MG/DAY,MG,50,NA,ORAL,NA,NA,PROGRESSION,NA,7000,NA
158,e0127e51-43ba-4536-bc9d-004591f9c627,TCGA.CZ.5462,TCGA-CZ-5462-D9045,71a635c2-508f-4151-b41c-0542821055e0,2011-3-11,SUNITINIB,NA,CHEMOTHERAPY,15,FALSE,127,NA,NA,NA,NA,NA,NA,MG/DAY,NA,50,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
159,6b79d20c-d5bc-4580-837e-b36dfd0c199c,TCGA.CZ.5464,TCGA-CZ-5464-D9059,a7793c40-e76c-4b4e-92da-e30f7a1c58b2,2011-3-11,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,52,FALSE,571,NA,NA,NA,NA,NA,NA,MG/DAY,NA,50,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
160,6b79d20c-d5bc-4580-837e-b36dfd0c199c,TCGA.CZ.5464,TCGA-CZ-5464-D19220,27449df9-bfc7-40cf-a102-4e3024f8b6b0,2011-12-6,PAZOPANIB,NA,TARGETED MOLECULAR THERAPY,1407,FALSE,1730,NA,NA,NA,NA,NA,NA,MG,NA,800,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
161,6205c2d8-d431-4c4c-8ac6-ee407170e833,TCGA.CZ.5469,TCGA-CZ-5469-D9073,51e67e71-cb66-4363-b6fb-7c6cb7037aed,2011-3-11,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,223,FALSE,597,NA,NA,NA,NA,NA,NA,MG/DAY,NA,37.5,NA,ORAL,NA,NA,PROGRESSION,NA,NA,NA
162,f6d28a1d-6691-4ac1-8afb-ab0e7dcef867,TCGA.DV.5565,TCGA-DV-5565-D13877,aff45daf-b926-4e59-80ac-70ba3f35d908,2011-7-18,ZD6474,NA,TARGETED MOLECULAR THERAPY,1189,TRUE,NA,NA,NA,NA,NA,6,NA,MG,NA,200,1,ORAL,NA,NA,RECURRENCE,NA,NA,NA
163,EF2D7EF5-CDFC-48C9-B3FE-6EAF3BE1106D,TCGA.DV.A4VX,TCGA-DV-A4VX-D39044,7880BC8A-7E1D-42DB-A721-6B336D67A093,2013-12-3,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,56,FALSE,482,STABLE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE
164,EF2D7EF5-CDFC-48C9-B3FE-6EAF3BE1106D,TCGA.DV.A4VX,TCGA-DV-A4VX-D39045,0E637E76-7F7E-442D-B3DE-F1737B52A179,2013-12-3,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,482,FALSE,1503,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE
165,3F0A2571-C088-4735-8152-61F6FD60AC63,TCGA.G6.A5PC,TCGA-G6-A5PC-D44703,5DC3019B-3C23-44EF-9AE9-FF381CF2320F,2013-6-25,SUTENT,NA,TARGETED MOLECULAR THERAPY,62,FALSE,208,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
166,28011111-4A01-4CDC-8D6B-7223FB2C501B,TCGA.G6.A8L6,TCGA-G6-A8L6-D58227,8CA2D5C3-74D7-46B8-BA9B-52BEB3D62017,2014-4-2,AVASTIN,NA,IMMUNOTHERAPY,276,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
167,28011111-4A01-4CDC-8D6B-7223FB2C501B,TCGA.G6.A8L6,TCGA-G6-A8L6-D58225,2D08B0B9-FCAE-43BE-92B4-1D58B09E5E00,2014-4-3,SUTENT,NA,CHEMOTHERAPY,73,FALSE,211,STABLE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
168,28011111-4A01-4CDC-8D6B-7223FB2C501B,TCGA.G6.A8L6,TCGA-G6-A8L6-D58226,55CA8E78-C80B-4957-8A71-16D55025F6D7,2014-4-3,AXITNIB,NA,CHEMOTHERAPY,252,FALSE,272,STABLE DISEASE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
